药用辅料市场规模、份额、成长分析（按产品类型、功能、配方、来源、最终用户、地区）- 2025-2032 年产业预测

2023 年全球药用辅料市场规模为 91 亿美元，预计将从 2024 年的 96.3 亿美元成长到 2032 年的 151.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.8%。

由于对创新药物的需求不断增加以及药物输送技术的进步，药用辅料市场预计将大幅成长。开发新药投资的增加和学名药需求的激增为辅料製造商创造了充足的机会。此外，全球製药製造活动的扩张预计将进一步提升市场前景。生物製药销售的扩大可能会增加对特殊辅料的需求。然而，生产成本上升、法规严格、原材料供应波动以及替代品的竞争等挑战可能会阻碍市场进步。预计北美和亚太地区仍将是药用辅料的主要市场，这表明未来几年这些地区将具有巨大的商业性潜力。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

药用辅料市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 有机化学品
  • 碳水化合物
  • 糖
  • 淀粉
  • 纤维素及其衍生物
  • 石化产品
  • 乙二醇
  • 聚维酮
  • 矿物碳氢化合物
  • 蛋白质
  • 明胶
  • 白蛋白
• 无机化学品
  • 磷酸钙
  • 碳酸钙
  • 硬脂酸镁
  • 氯化钠
  • 二氧化硅
• 其他的
  • 油脂化工产品
  • 天然辅料

药用辅料市场规模：功能与复合年增长率（2025-2032）

• 市场概览
• 黏合剂
• 填充剂/稀释剂
• 崩坏
• 被覆剂
• 润滑剂
• 防腐剂
• 香料和甜味剂
• 着色剂
• 溶剂
• 其他的

药用辅料市场规模（按配方和复合年增长率） (2025-2032)

• 市场概览
• 口服製剂
  • 药片
  • 胶囊
  • 粉末
  • 糖浆
• 局部製剂
  • 奶油
  • 软膏
  • 凝胶
• 肠外製剂
  • 注射
  • 点滴
• 吸入剂型
  • 干粉吸入器（DPI）
  • 定量喷雾吸入器（MDI）
• 眼药水
• 鼻腔製剂
• 栓剂

药用辅料市场规模（按来源和复合年增长率）（2025-2032）

• 市场概览
• 自然的
  • 植物来源
  • 动物来源
• 合成
  • 全合成
  • 半合成

药用辅料市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 製药公司
• 生物製药公司
• 契约製造组织（CMO）
• 合约研究组织（CRO）

药用辅料市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Evonik Industries AG-Germany
• Ashland Global Holdings Inc.-USA
• International Flavors & Fragrances Inc.-USA
• Roquette Freres-France
• Fuji Chemical Industries Co., Ltd.-Japan
• Wacker Chemie AG-Germany
• MEGGLE GmbH & Co. KG-Germany
• Key Developments
• Biogrund GmbH-Germany
• Nitika Pharmaceutical Specialties Pvt. Ltd.-India
• JM Huber Corporation-USA
• Kerry Group plc-Ireland
• Colorcon Inc.-USA
• Merck KGaA-Germany
• DFE Pharma-Germany
• Finar Limited-India
• Corel Pharma Chem-India
• Gattefosse-France
• BASF SE-Germany
• DowDuPont Inc.-USA

结论和建议

Global Pharmaceutical Excipients Market size was valued at USD 9.1 billion in 2023 and is poised to grow from USD 9.63 billion in 2024 to USD 15.12 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The pharmaceutical excipients market is poised for significant growth driven by rising demand for innovative drugs and advancements in drug delivery technologies. Increased investments in novel drug development and a surging demand for generic medications present ample opportunities for excipient manufacturers. Additionally, the global expansion of pharmaceutical manufacturing activities is expected to further enhance market prospects. The growing sales of biologics will likely boost demand for specialized excipients. However, challenges such as high manufacturing costs, stringent regulations, raw material supply fluctuations, and competition from alternatives may hinder market progress. North America and the Asia Pacific regions are projected to remain the dominant markets for pharmaceutical excipients, indicating robust commercial potential in these areas in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global Pharmaceutical Excipients Market is segmented by Product Type, Functionality, Formulation, Source, End User and region. Based on Product Type, the market is segmented into Organic Chemicals, Inorganic Chemicals and Others. Based on Functionality, the market is segmented into Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants, Preservatives, Flavors and Sweeteners, Coloring Agents, Solvents and Others. Based on Formulation, the market is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations, Inhalation Formulations, Ophthalmic Formulations, Nasal Formulations and Suppositories. Based on Source, the market is segmented into Natural and Synthetic. Based on End User, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Excipients Market

The escalating costs of drugs and pharmaceuticals globally have sparked a significant surge in the demand for generic medicines. This trend is fueled by a rising focus on enhancing healthcare accessibility and lowering overall healthcare expenses. As a result, the market for generic medicines is expected to see substantial growth, which, in turn, will positively influence the development of the pharmaceutical excipients market. The increasing popularity of generic alternatives is driving innovation and competition, further propelling advancements within the excipients sector, making it an essential component of the pharmaceutical manufacturing process as the industry adapts to these market dynamics.

Restraints in the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market faces significant restraints primarily due to the high research and development costs associated with excipient formulation. The intricate development process necessitates extensive investment throughout the entire product lifecycle, which can elevate overall expenses. Additionally, the growing reliance on advanced manufacturing equipment further contributes to these elevated production costs. As a result, this combination of high development and manufacturing expenses is likely to hinder sales growth in the pharmaceutical excipients sector in the foreseeable future, posing challenges for market expansion and profitability.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a significant trend towards the incorporation of natural and biodegradable ingredients. As consumers increasingly gravitate towards wellness and sustainability, there is a rising demand for drug formulations that utilize natural excipients, steering away from traditional chemical-based alternatives. This shift is driven by a growing demographic that prioritizes health-conscious choices and seeks transparency in product formulations. Consequently, pharmaceutical excipient manufacturers are presented with lucrative opportunities to innovate and expand their product lines by integrating eco-friendly components, thereby aligning with consumer preferences and contributing to the overall growth of this dynamic market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Organic Chemicals
  • Carbohydrates
  • Sugars
  • Starches
  • Cellulose and Derivatives
  • Petrochemicals
  • Glycols
  • Povidone
  • Mineral Hydrocarbons
  • Proteins
  • Gelatin
  • Albumin
• Inorganic Chemicals
  • Calcium Phosphates
  • Calcium Carbonate
  • Magnesium Stearate
  • Sodium Chloride
  • Silicon Dioxide
• Others
  • Oleochemicals
  • Natural Excipients

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2025-2032)

• Market Overview
• Binders
• Fillers/Diluents
• Disintegrants
• Coating Agents
• Lubricants
• Preservatives
• Flavors and Sweeteners
• Coloring Agents
• Solvents
• Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Oral Formulations
  • Tablets
  • Capsules
  • Powders
  • Syrups
• Topical Formulations
  • Creams
  • Ointments
  • Gels
• Parenteral Formulations
  • Injections
  • IV Infusions
• Inhalation Formulations
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
• Ophthalmic Formulations
• Nasal Formulations
• Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2025-2032)

• Market Overview
• Natural
  • Plant-based
  • Animal-based
• Synthetic
  • Fully synthetic
  • Semi-synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2025-2032)

• North America (Product Type, Functionality, Formulation, Source, End User)
  • US
  • Canada
• Europe (Product Type, Functionality, Formulation, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Functionality, Formulation, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Evonik Industries AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Flavors & Fragrances Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGGLE GmbH & Co. KG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Biogrund GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nitika Pharmaceutical Specialties Pvt. Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.M. Huber Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Finar Limited - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corel Pharma Chem - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DowDuPont Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations